CCND1 and cholangiocarcinoma: The significant down-regulation of cyclin D1 level in all three CCA cell lines exposing to salirasib alone suggested that salirasib could affect cyclin D1 expression in CCA cells as reported in other cancer cells (Charette et al., 2010).